IL6 and Stroke: Elevated IL-6 levels have indicated significant associations with higher NIHSS scores, worse mRS scores, and increased mortality at three months post-stroke, highlighting its potential utility as a prognostic biomarker for poor functional outcomes and long-term survival [61].